Fetal blood sampling

Objective We sought to review indications, technical aspects, risks, and recommendations for fetal blood sampling (FBS). Methods A systematic review was performed using MEDLINE, PubMed, EMBASE, and Cochrane Library using the terms “fetal blood sampling,” “percutaneous umbilical blood sampling,” and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of obstetrics and gynecology 2013-09, Vol.209 (3), p.170-180
Hauptverfasser: Berry, Stanley M., MD, Stone, Joanne, MD, Norton, Mary E., MD, Johnson, Donna, MD, Berghella, Vincenzo, MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 180
container_issue 3
container_start_page 170
container_title American journal of obstetrics and gynecology
container_volume 209
creator Berry, Stanley M., MD
Stone, Joanne, MD
Norton, Mary E., MD
Johnson, Donna, MD
Berghella, Vincenzo, MD
description Objective We sought to review indications, technical aspects, risks, and recommendations for fetal blood sampling (FBS). Methods A systematic review was performed using MEDLINE, PubMed, EMBASE, and Cochrane Library using the terms “fetal blood sampling,” “percutaneous umbilical blood sampling,” and “cordocentesis.” The search was restricted to English-language articles published from 1966 through July 2012. Priority was given to articles reporting original research, in particular randomized controlled trials, although review articles and commentaries also were consulted. Abstracts of research presented at symposia and scientific conferences were not considered adequate for inclusion in this document. Evidence reports and guidelines published by organizations or institutions such as the National Institutes of Health, Agency for Health Research and Quality, American Congress of Obstetricians and Gynecologists, and Society for Maternal-Fetal Medicine were also reviewed, and additional studies were located by reviewing bibliographies of identified articles. Grade (Grading of Recommendations Assessment, Development, and Evaluation) methodology was employed for defining strength of recommendations and rating quality of evidence. Consistent with US Preventive Task Force guidelines, references were evaluated for quality based on the highest level of evidence. Results and Recommendations Ultrasound-guided FBS is the only procedure that provides direct access to the fetal circulation. When invasive testing is planned for suspected severe fetal anemia or thrombocytopenia, we recommend FBS as the procedure of choice, with availability of immediate transfusion if confirmed. We recommend against the use of FBS for indications in which other less invasive, and therefore lower risk, alternatives are available. The overall success rate of FBS is high, and blood samples can be obtained in >98% of patients. We suggest that counseling for FBS include discussion about the potential risk of FBS that may include, but may not be limited to: bleeding from puncture site (20-30%); fetal bradycardia (5-10%); pregnancy loss (≥1.3%, depending on indication, gestational age, and placental penetration); and vertical transmission of hepatitis or human immunodeficiency virus. We recommend that FBS be performed by experienced operators at centers with expertise in invasive fetal procedures when feasible.
doi_str_mv 10.1016/j.ajog.2013.07.014
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1428519487</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0002937813007461</els_id><sourcerecordid>1428519487</sourcerecordid><originalsourceid>FETCH-LOGICAL-c455t-52e0d17e05d635a5f5234169f08bd5443cba86feb4fda0d5311a5897f0878393</originalsourceid><addsrcrecordid>eNp9kc1Lw0AQxRdRbK3ePHmQHr0kzn5lNyCCFKtCwYO9L5vdSUnMR82mQv97E6oePHgahnnvwfsNIVcUYgo0uS1jW7abmAHlMagYqDgiUwqpihKd6GMyBQAWpVzpCTkLoRxXlrJTMmE8VZqJZEoul9jbap5Vbevnwdbbqmg25-Qkt1XAi-85I-vl43rxHK1en14WD6vICSn7SDIETxWC9AmXVuaScUGTNAedeSkEd5nVSY6ZyL0FLzmlVupUDXelecpn5OYQu-3ajx2G3tRFcFhVtsF2FwwVTEuaCq0GKTtIXdeG0GFutl1R225vKJgRhinNCMOMMAwoM8AYTNff-busRv9r-Wk_CO4OAhxKfhbYmeAKbBz6okPXG98W_-ff_7G7gV7hbPWOewxlu-uaAZ-hJjAD5m3kP36DcgAlEsq_AEVGgfU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1428519487</pqid></control><display><type>article</type><title>Fetal blood sampling</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Berry, Stanley M., MD ; Stone, Joanne, MD ; Norton, Mary E., MD ; Johnson, Donna, MD ; Berghella, Vincenzo, MD</creator><creatorcontrib>Berry, Stanley M., MD ; Stone, Joanne, MD ; Norton, Mary E., MD ; Johnson, Donna, MD ; Berghella, Vincenzo, MD ; Society for Maternal-Fetal Medicine (SMFM)</creatorcontrib><description>Objective We sought to review indications, technical aspects, risks, and recommendations for fetal blood sampling (FBS). Methods A systematic review was performed using MEDLINE, PubMed, EMBASE, and Cochrane Library using the terms “fetal blood sampling,” “percutaneous umbilical blood sampling,” and “cordocentesis.” The search was restricted to English-language articles published from 1966 through July 2012. Priority was given to articles reporting original research, in particular randomized controlled trials, although review articles and commentaries also were consulted. Abstracts of research presented at symposia and scientific conferences were not considered adequate for inclusion in this document. Evidence reports and guidelines published by organizations or institutions such as the National Institutes of Health, Agency for Health Research and Quality, American Congress of Obstetricians and Gynecologists, and Society for Maternal-Fetal Medicine were also reviewed, and additional studies were located by reviewing bibliographies of identified articles. Grade (Grading of Recommendations Assessment, Development, and Evaluation) methodology was employed for defining strength of recommendations and rating quality of evidence. Consistent with US Preventive Task Force guidelines, references were evaluated for quality based on the highest level of evidence. Results and Recommendations Ultrasound-guided FBS is the only procedure that provides direct access to the fetal circulation. When invasive testing is planned for suspected severe fetal anemia or thrombocytopenia, we recommend FBS as the procedure of choice, with availability of immediate transfusion if confirmed. We recommend against the use of FBS for indications in which other less invasive, and therefore lower risk, alternatives are available. The overall success rate of FBS is high, and blood samples can be obtained in &gt;98% of patients. We suggest that counseling for FBS include discussion about the potential risk of FBS that may include, but may not be limited to: bleeding from puncture site (20-30%); fetal bradycardia (5-10%); pregnancy loss (≥1.3%, depending on indication, gestational age, and placental penetration); and vertical transmission of hepatitis or human immunodeficiency virus. We recommend that FBS be performed by experienced operators at centers with expertise in invasive fetal procedures when feasible.</description><identifier>ISSN: 0002-9378</identifier><identifier>EISSN: 1097-6868</identifier><identifier>DOI: 10.1016/j.ajog.2013.07.014</identifier><identifier>PMID: 23978246</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Anesthesia, Local ; Antibiotic Prophylaxis ; cordocentesis ; Cordocentesis - adverse effects ; Cordocentesis - methods ; Female ; fetal blood sampling ; Humans ; indications ; Obstetrics and Gynecology ; percutaneous umbilical cord blood sampling ; Pregnancy ; risks ; technical aspects</subject><ispartof>American journal of obstetrics and gynecology, 2013-09, Vol.209 (3), p.170-180</ispartof><rights>Mosby, Inc.</rights><rights>2013 Mosby, Inc.</rights><rights>Copyright © 2013 Mosby, Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c455t-52e0d17e05d635a5f5234169f08bd5443cba86feb4fda0d5311a5897f0878393</citedby><cites>FETCH-LOGICAL-c455t-52e0d17e05d635a5f5234169f08bd5443cba86feb4fda0d5311a5897f0878393</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ajog.2013.07.014$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23978246$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Berry, Stanley M., MD</creatorcontrib><creatorcontrib>Stone, Joanne, MD</creatorcontrib><creatorcontrib>Norton, Mary E., MD</creatorcontrib><creatorcontrib>Johnson, Donna, MD</creatorcontrib><creatorcontrib>Berghella, Vincenzo, MD</creatorcontrib><creatorcontrib>Society for Maternal-Fetal Medicine (SMFM)</creatorcontrib><title>Fetal blood sampling</title><title>American journal of obstetrics and gynecology</title><addtitle>Am J Obstet Gynecol</addtitle><description>Objective We sought to review indications, technical aspects, risks, and recommendations for fetal blood sampling (FBS). Methods A systematic review was performed using MEDLINE, PubMed, EMBASE, and Cochrane Library using the terms “fetal blood sampling,” “percutaneous umbilical blood sampling,” and “cordocentesis.” The search was restricted to English-language articles published from 1966 through July 2012. Priority was given to articles reporting original research, in particular randomized controlled trials, although review articles and commentaries also were consulted. Abstracts of research presented at symposia and scientific conferences were not considered adequate for inclusion in this document. Evidence reports and guidelines published by organizations or institutions such as the National Institutes of Health, Agency for Health Research and Quality, American Congress of Obstetricians and Gynecologists, and Society for Maternal-Fetal Medicine were also reviewed, and additional studies were located by reviewing bibliographies of identified articles. Grade (Grading of Recommendations Assessment, Development, and Evaluation) methodology was employed for defining strength of recommendations and rating quality of evidence. Consistent with US Preventive Task Force guidelines, references were evaluated for quality based on the highest level of evidence. Results and Recommendations Ultrasound-guided FBS is the only procedure that provides direct access to the fetal circulation. When invasive testing is planned for suspected severe fetal anemia or thrombocytopenia, we recommend FBS as the procedure of choice, with availability of immediate transfusion if confirmed. We recommend against the use of FBS for indications in which other less invasive, and therefore lower risk, alternatives are available. The overall success rate of FBS is high, and blood samples can be obtained in &gt;98% of patients. We suggest that counseling for FBS include discussion about the potential risk of FBS that may include, but may not be limited to: bleeding from puncture site (20-30%); fetal bradycardia (5-10%); pregnancy loss (≥1.3%, depending on indication, gestational age, and placental penetration); and vertical transmission of hepatitis or human immunodeficiency virus. We recommend that FBS be performed by experienced operators at centers with expertise in invasive fetal procedures when feasible.</description><subject>Anesthesia, Local</subject><subject>Antibiotic Prophylaxis</subject><subject>cordocentesis</subject><subject>Cordocentesis - adverse effects</subject><subject>Cordocentesis - methods</subject><subject>Female</subject><subject>fetal blood sampling</subject><subject>Humans</subject><subject>indications</subject><subject>Obstetrics and Gynecology</subject><subject>percutaneous umbilical cord blood sampling</subject><subject>Pregnancy</subject><subject>risks</subject><subject>technical aspects</subject><issn>0002-9378</issn><issn>1097-6868</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc1Lw0AQxRdRbK3ePHmQHr0kzn5lNyCCFKtCwYO9L5vdSUnMR82mQv97E6oePHgahnnvwfsNIVcUYgo0uS1jW7abmAHlMagYqDgiUwqpihKd6GMyBQAWpVzpCTkLoRxXlrJTMmE8VZqJZEoul9jbap5Vbevnwdbbqmg25-Qkt1XAi-85I-vl43rxHK1en14WD6vICSn7SDIETxWC9AmXVuaScUGTNAedeSkEd5nVSY6ZyL0FLzmlVupUDXelecpn5OYQu-3ajx2G3tRFcFhVtsF2FwwVTEuaCq0GKTtIXdeG0GFutl1R225vKJgRhinNCMOMMAwoM8AYTNff-busRv9r-Wk_CO4OAhxKfhbYmeAKbBz6okPXG98W_-ff_7G7gV7hbPWOewxlu-uaAZ-hJjAD5m3kP36DcgAlEsq_AEVGgfU</recordid><startdate>20130901</startdate><enddate>20130901</enddate><creator>Berry, Stanley M., MD</creator><creator>Stone, Joanne, MD</creator><creator>Norton, Mary E., MD</creator><creator>Johnson, Donna, MD</creator><creator>Berghella, Vincenzo, MD</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20130901</creationdate><title>Fetal blood sampling</title><author>Berry, Stanley M., MD ; Stone, Joanne, MD ; Norton, Mary E., MD ; Johnson, Donna, MD ; Berghella, Vincenzo, MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c455t-52e0d17e05d635a5f5234169f08bd5443cba86feb4fda0d5311a5897f0878393</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Anesthesia, Local</topic><topic>Antibiotic Prophylaxis</topic><topic>cordocentesis</topic><topic>Cordocentesis - adverse effects</topic><topic>Cordocentesis - methods</topic><topic>Female</topic><topic>fetal blood sampling</topic><topic>Humans</topic><topic>indications</topic><topic>Obstetrics and Gynecology</topic><topic>percutaneous umbilical cord blood sampling</topic><topic>Pregnancy</topic><topic>risks</topic><topic>technical aspects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Berry, Stanley M., MD</creatorcontrib><creatorcontrib>Stone, Joanne, MD</creatorcontrib><creatorcontrib>Norton, Mary E., MD</creatorcontrib><creatorcontrib>Johnson, Donna, MD</creatorcontrib><creatorcontrib>Berghella, Vincenzo, MD</creatorcontrib><creatorcontrib>Society for Maternal-Fetal Medicine (SMFM)</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of obstetrics and gynecology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Berry, Stanley M., MD</au><au>Stone, Joanne, MD</au><au>Norton, Mary E., MD</au><au>Johnson, Donna, MD</au><au>Berghella, Vincenzo, MD</au><aucorp>Society for Maternal-Fetal Medicine (SMFM)</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Fetal blood sampling</atitle><jtitle>American journal of obstetrics and gynecology</jtitle><addtitle>Am J Obstet Gynecol</addtitle><date>2013-09-01</date><risdate>2013</risdate><volume>209</volume><issue>3</issue><spage>170</spage><epage>180</epage><pages>170-180</pages><issn>0002-9378</issn><eissn>1097-6868</eissn><abstract>Objective We sought to review indications, technical aspects, risks, and recommendations for fetal blood sampling (FBS). Methods A systematic review was performed using MEDLINE, PubMed, EMBASE, and Cochrane Library using the terms “fetal blood sampling,” “percutaneous umbilical blood sampling,” and “cordocentesis.” The search was restricted to English-language articles published from 1966 through July 2012. Priority was given to articles reporting original research, in particular randomized controlled trials, although review articles and commentaries also were consulted. Abstracts of research presented at symposia and scientific conferences were not considered adequate for inclusion in this document. Evidence reports and guidelines published by organizations or institutions such as the National Institutes of Health, Agency for Health Research and Quality, American Congress of Obstetricians and Gynecologists, and Society for Maternal-Fetal Medicine were also reviewed, and additional studies were located by reviewing bibliographies of identified articles. Grade (Grading of Recommendations Assessment, Development, and Evaluation) methodology was employed for defining strength of recommendations and rating quality of evidence. Consistent with US Preventive Task Force guidelines, references were evaluated for quality based on the highest level of evidence. Results and Recommendations Ultrasound-guided FBS is the only procedure that provides direct access to the fetal circulation. When invasive testing is planned for suspected severe fetal anemia or thrombocytopenia, we recommend FBS as the procedure of choice, with availability of immediate transfusion if confirmed. We recommend against the use of FBS for indications in which other less invasive, and therefore lower risk, alternatives are available. The overall success rate of FBS is high, and blood samples can be obtained in &gt;98% of patients. We suggest that counseling for FBS include discussion about the potential risk of FBS that may include, but may not be limited to: bleeding from puncture site (20-30%); fetal bradycardia (5-10%); pregnancy loss (≥1.3%, depending on indication, gestational age, and placental penetration); and vertical transmission of hepatitis or human immunodeficiency virus. We recommend that FBS be performed by experienced operators at centers with expertise in invasive fetal procedures when feasible.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>23978246</pmid><doi>10.1016/j.ajog.2013.07.014</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0002-9378
ispartof American journal of obstetrics and gynecology, 2013-09, Vol.209 (3), p.170-180
issn 0002-9378
1097-6868
language eng
recordid cdi_proquest_miscellaneous_1428519487
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Anesthesia, Local
Antibiotic Prophylaxis
cordocentesis
Cordocentesis - adverse effects
Cordocentesis - methods
Female
fetal blood sampling
Humans
indications
Obstetrics and Gynecology
percutaneous umbilical cord blood sampling
Pregnancy
risks
technical aspects
title Fetal blood sampling
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T18%3A27%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Fetal%20blood%20sampling&rft.jtitle=American%20journal%20of%20obstetrics%20and%20gynecology&rft.au=Berry,%20Stanley%20M.,%20MD&rft.aucorp=Society%20for%20Maternal-Fetal%20Medicine%20(SMFM)&rft.date=2013-09-01&rft.volume=209&rft.issue=3&rft.spage=170&rft.epage=180&rft.pages=170-180&rft.issn=0002-9378&rft.eissn=1097-6868&rft_id=info:doi/10.1016/j.ajog.2013.07.014&rft_dat=%3Cproquest_cross%3E1428519487%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1428519487&rft_id=info:pmid/23978246&rft_els_id=1_s2_0_S0002937813007461&rfr_iscdi=true